- Jun 20, 2014
- 5,083
- 7,592
This new AstraZeneca drug sounds pretty impressive, TBH. An injectable antibody therapy to prevent COVID similar to existing monoclonal antibody therapy, but doesn't require infusion. Doesn't work if you already have COVID though.
- primary use would be for a minority of people with chronic diseases and other conditions that could render vaccines less effective
- 77% efficacy in reducing risk of symptomatic Covid-19 compared with a placebo in late-stage clinical trials testing its usefulness as a preventive treatment
AstraZeneca Submits Preventive Covid-19 Treatment for FDA Authorization
The company asked U.S. regulators for emergency-use authorization for an antibody drug that earlier this year showed strong efficacy in preventing symptomatic Covid-19, offering a potential alternative in evading the disease.
www.wsj.com
AstraZeneca seeks U.S. approval for drug cocktail to prevent COVID
AstraZeneca has requested emergency approval from U.S. regulators for its antibody cocktail, the first protective shot other than vaccines against COVID-19, another potential major step in the global fight to combat the virus.
www.reuters.com